- Home
- SOL vs CRVO Comparison
SOL vs CRVO Comparison
Compare SOL & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SOL | CRVO |
|---|---|---|
| Founded | 2005 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 98.5M | 89.1M |
| IPO Year | 2008 | N/A |
Fundamental Metrics
Financial Performance| Metric | SOL | CRVO |
|---|---|---|
| Price | $1.94 | $8.27 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 6 |
| Target Price | $4.50 | ★ $21.50 |
| AVG Volume (30 Days) | ★ 270.2K | 79.7K |
| Earning Date | 11-14-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $71,226,000.00 | $6,159,786.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $45.37 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.04 | $1.80 |
| 52 Week High | $2.30 | $16.94 |
Technical Indicators
Market Signals| Indicator | SOL | CRVO |
|---|---|---|
| Relative Strength Index (RSI) | 68.41 | 50.02 |
| Support Level | $1.89 | $8.13 |
| Resistance Level | $1.95 | $9.22 |
| Average True Range (ATR) | 0.05 | 0.64 |
| MACD | 0.02 | -0.11 |
| Stochastic Oscillator | 96.54 | 29.55 |
Price Performance
Historical ComparisonAbout SOL Emeren Group Ltd each representing 10 shares
Emeren Group Ltd is a renewable energy producer. Its portfolio consists of solar projects and Independent Power Producer (IPP) assets, and it also has globalised Battery Energy Storage System (BESS) capacity. The group specializes in the solar project lifecycle, development, and from construction to financing. It has three reportable segments; Solar power project development, EPC services, and Electricity generation. Majority of revenue is From Electricity Generation. The company operates in China, USA, Germany, UK, Spain, France, Poland, Italy, Hungary, Luxembourg. Majority of revenue is from Italy.
About CRVO CervoMed Inc.
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.